This study is testing whether adding an experimental drug called ZN-c3 to an approved chemotherapy (gemcitabine) can help control advanced pancreatic cancer that has worsened after initial treatment. The main goal is to see if this combination can keep the cancer from growing for…
Phase: PHASE2 • Sponsor: Brandon Huffman, MD • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC